Fichelson, S <br/><br/>
Tyrosine residues of the erythropoietin receptor are dispensable for erythroid differentiation of human CD34+ progenitors.  [electronic resource] 

 -  Biochemical and biophysical research communications  Mar 1999 
 - 685-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-291X 
<br/><br/><label>Standard No.: </label>10.1006/bbrc.1999.0340  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD34--analysis<br/>Cell Differentiation--drug effects<br/>Cell Division--drug effects<br/>Erythrocytes--cytology<br/>Erythroid Precursor Cells--cytology<br/>Fetal Blood--cytology<br/>Genetic Vectors--genetics<br/>Growth Substances--pharmacology<br/>Humans<br/>Phosphorylation--drug effects<br/>Precipitin Tests<br/>Prolactin--pharmacology<br/>RNA, Viral--analysis<br/>Receptors, Erythropoietin--chemistry<br/>Receptors, Prolactin--chemistry<br/>Recombinant Fusion Proteins--biosynthesis<br/>Retroviridae--genetics<br/>Sequence Deletion<br/>Signal Transduction--drug effects<br/>Transduction, Genetic<br/>Tumor Cells, Cultured<br/>Tyrosine--genetics